| 5.56 Delayed Data As of Sep 13 |  +0.05 / +0.91%Today’s Change | 3.90 Today|||52-Week Range 7.84 | -24.86% Year-to-Date |
| Why Is Pacific Biosciences (PACB) Up 0.2% Since Last Earnings Report? Sep 05 / Zacks.com - Paid Partner Content | Merger or Not, Pacific Biosciences Needs to Deliver Sep 04 / MotleyFool.com - Paid Partner Content |
| Previous close | 5.51 |
| Today’s open | 5.54 |
| Day’s range | 5.49 - 5.68 |
| Volume | 685,285 |
| Average volume (3 months) | 1,674,052 |
| Market cap | $839.3M |
| Earnings growth (last year) | +12.74% |
| Earnings growth (this year) | +13.82% |
| Earnings growth (next 5 years) | +30.00% |
| Revenue growth (last year) | -15.88% |
| P/E ratio | NM |
| Price/Sales | 12.71 |
| Price/Book | 7.23 |
| Today’s change | Today’s % change | |
|---|---|---|
| FLDMFluidigm Corp | -0.06 | -1.10% |
| --Fluidigm Corp | -0.06 | -1.10% |
| HBIOHarvard Bioscience I... | +0.05 | +1.61% |
| BIOBBio Rad Laboratories... | 0.00 | 0.00% |
| Next reporting date | October 31, 2019 |
| EPS forecast (this quarter) | -$0.15 |
| Annual revenue (last year) | $78.6M |
| Annual profit (last year) | -$102.6M |
| Net profit margin | -130.44% |
Sector Health Technology |
Industry Biotechnology |
Executive Chairman, President & CEO Michael W. Hunkapiller |
CFO, Principal Accounting Officer & Senior VP Susan K. Barnes |
Corporate headquarters Menlo Park, California |
